The STATus of miR-21 in apoptosis

Por Hurt, Elaine M., Farrar, William L.
Publicado em 2007

Clinical significance of Polycomb gene expression in brain tumors

Por Crea, Francesco, Hurt, Elaine M, Farrar, William L
Publicado em 2010

Cancer stem cell plasticity and tumor hierarchy

Por Cabrera, Marina Carla, Hollingsworth, Robert E, Hurt, Elaine M
Publicado no World J Stem Cells (2015)

Integrated molecular profiling of SOD2 expression in multiple myeloma

Por Hurt, Elaine M., Thomas, Suneetha B., Peng, Benjamin, Farrar, William L.
Publicado em 2007

Effects of SOD2 Silencing on Androgen Receptor Function and Gene Regulation: Implications for Castration-Resistant Prostate Cancer

Por Sharifi, Nima, Hurt, Elaine M., Thomas, Suneetha B., Farrar, William L.
Publicado em 2008

Epigenetic regulation of CpG promoter methylation in invasive prostate cancer cells

Por Mathews, Lesley A, Hurt, Elaine M, Zhang, Xiaohu, Farrar, William L
Publicado em 2010

Genomic Analysis of Invasive Human Bone Marrow Derived Mesenchymal Stem Cells

Por Mathews, Lesley A, Hurt, Elaine M, Zhang, Xiaohu, Farrar, William L
Publicado em 2013

CO-EXPRESSION OF THE TOLERAGENIC GLYCOPROTEIN, CD200, WITH MARKERS FOR CANCER STEM CELLS

Por Kawasaki, Brian T., Mistree, Tashan, Hurt, Elaine M., Kalathur, Madhuri, Farrar, William L.
Publicado em 2007

A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma

Por Wright, George, Tan, Bruce, Rosenwald, Andreas, Hurt, Elaine H., Wiestner, Adrian, Staudt, Louis M.
Publicado em 2003

Genomic profiling of tumor initiating prostatospheres

Por Duhagon, Maria Ana, Hurt, Elaine M, Sotelo-Silveira, Jose R, Zhang, Xiaohu, Farrar, William L
Publicado em 2010

Increased expression of DNA repair genes in invasive human pancreatic cancer cells

Por Mathews, Lesley A., Cabarcas, Stephanie M., Hurt, Elaine M., Zhang, Xiaohu, Jaffee, Elizabeth M., Farrar, William L.
Publicado em 2011

BMI1 Silencing Enhances Docetaxel Activity and Impairs Antioxidant Response in Prostate Cancer

Por Crea, Francesco, Duhagon Serrat, Maria A., Hurt, Elaine M, Thomas, Suneetha B., Danesi, Romano, Farrar, William L
Publicado em 2011

Effects of the sesquiterpene lactone parthenolide on prostate tumor-initiating cells: an integrated molecular profiling approach

Por Kawasaki, Brian T., Hurt, Elaine M., Kalathur, Madhuri, Duhagon, Maria Ana, Milner, John A., Kim, Young S., Farrar, William L.
Publicado em 2009

Gossypol induces apoptosis by activating p53 in prostate cancer cells and prostate tumor-initiating cells

Por Volate, Suresh R., Kawasaki, Brian T., Hurt, Elaine M., Milner, John A., Kim, Young S., White, Jeffrey, Farrar, William L.
Publicado em 2010

Identification of Vitronectin as an Extrinsic Inducer of Cancer Stem Cell Differentiation and Tumor Formation

Por Hurt, Elaine M., Chan, King, Serrat, Maria Ana Duhagon, Thomas, Suneetha B., Veenstra, Timothy D., Farrar, William L.
Publicado em 2010

Pharmacologic disruption of Polycomb Repressive Complex 2 inhibits tumorigenicity and tumor progression in prostate cancer

Por Crea, Francesco, Hurt, Elaine M, Mathews, Lesley A, Cabarcas, Stephanie M, Sun, Lei, Marquez, Victor E, Danesi, Romano, Farrar, William L
Publicado em 2011

Invasive Prostate Cancer Cells Are Tumor Initiating Cells That Have A Stem Cell-Like Genomic Signature

Por Klarmann, George J., Hurt, Elaine M., Mathews, Lesley A., Zhang, Xiaohu, Duhagon, Maria A., Mistree, Tashan, Thomas, Suneetha B., Farrar, William L.
Publicado em 2009

The role of upregulated miRNAs and the identification of novel mRNA targets in prostatospheres

Por Cabarcas, Stephanie M, Thomas, Suneetha, Zhang, Xiaohu, Cherry, James M, Sebastian, Thomas, Yerramilli, Subu, Lader, Eric, Farrar, William L, Hurt, Elaine M
Publicado em 2011

Activation of Stat3 through a Phosphomimetic Serine727 Promotes Prostate Tumorigenesis Independent of Tyrosine705 phosphorylation

Por Qin, Haiyan R, Kim, Han-Jong, Kim, Joon-Young, Hurt, Elaine M, Klarmann, George J, Kawasaki, Brian T, Serrat, Maria A Duhagon, Farrar, William L
Publicado em 2008

EZH2 Is Required for Breast and Pancreatic Cancer Stem Cell Maintenance and Can Be Used as a Functional Cancer Stem Cell Reporter

Por van Vlerken, Lilian E., Kiefer, Christine M., Morehouse, Chris, Li, Ying, Groves, Chris, Wilson, Susan D., Yao, Yihong, Hollingsworth, Robert E., Hurt, Elaine M.
Publicado em 2013